These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8657258)

  • 1. Thrombophilia, homocystinuria, and mutation of the factor V gene.
    D'Angelo A; Fermo I; D'Angelo SV
    N Engl J Med; 1996 Jul; 335(4):289; author reply 290. PubMed ID: 8657258
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.
    Mandel H; Brenner B; Berant M; Rosenberg N; Lanir N; Jakobs C; Fowler B; Seligsohn U
    N Engl J Med; 1996 Mar; 334(12):763-8. PubMed ID: 8592550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial thrombosis and the role of thrombophilia.
    Boekholdt SM; Kramer MH
    Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis.
    Denninger MH; Helley D; Valla D; Guillin MC
    Thromb Haemost; 1997 Oct; 78(4):1297-8. PubMed ID: 9365003
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulation factor V and thrombophilia: background and mechanisms.
    Segers K; Dahlbäck B; Nicolaes GA
    Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished response to activated protein C is not correlated with severity of peripheral arterial occlusive disease.
    Köppel H; Renner W; Krippl P; Wascher TC; Pilger E
    Clin Lab; 2004; 50(11-12):689-93. PubMed ID: 15575311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
    Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
    Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
    Okumus G; Kiyan E; Arseven O; Tabak L; Diz-Kucukkaya R; Unlucerci Y; Abaci N; Unaltuna NE; Issever H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inherited thrombophilia and arterial diseases].
    Robert-Ebadi H; Boehlen F; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):331-2, 334-5. PubMed ID: 17370730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
    Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
    Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
    Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF
    Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and thrombophilia.
    Simioni P; Scudeller A; Girolami A
    N Engl J Med; 1995 May; 332(20):1382. PubMed ID: 7715653
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.